tyramine - CISMeF

Preferred Label : tyramine;

MeSH definition : An indirect sympathomimetic. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and monoamine oxidase so it prolongs the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals. Tyramine may be a neurotransmitter in some invertebrate nervous systems.; An indirect sympathomimetic that occurs naturally in cheese and other foods. Tyramine does not directly activate adrenergic receptors, but it can serve as a substrate for adrenergic uptake systems and MONOAMINE OXIDASE to prolong the actions of adrenergic transmitters. It also provokes transmitter release from adrenergic terminals and may be a neurotransmitter in some invertebrate nervous systems.;

MeSH synonym : 4-(2-aminoethyl)phenol; 4-Hydroxyphenethylamine; 4 Hydroxyphenethylamine;

MeSH hyponym : para-Tyramine; p-Tyramine;

MeSH CAS label : phenol, 4-(2-aminoethyl)-;

MeSH Related Number : 51-67-2 (Tyramine);

Registry Number MeSH : 51-67-2;

MeSH annotation : a biogenic amine;

Wikipedia link : https://en.wikipedia.org/wiki/Tyramine;

Codes EINECS : 200-115-8;

Is substance : O;

UNII : X8ZC7V0OX3;

InChIKey : DZGWFCGJZKJUFP-UHFFFAOYSA-N;

Details

Origin ID

D014439;

UMLS CUI

C0041479;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- tyramine [Substance BNPC]
Currated CISMeF NLP mapping
- Tyramine [LOINC component]
- Tyramine (substance) [SNOMED CT concept]
- tyramine [SNOMED Notion]
Pharmacological action(s)
- adrenergic uptake inhibitors [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- sympathomimetics [MeSH Descriptor]
Record concept(s)
- para-Tyramine [MeSH concept]
- tyramine [MeSH concept]
Related MeSH Supplementary Concept(s)
- (4-O-sulfamoyl)-N-tridecanoyl tyramine [MeSH Supplementary Concept]
- (E)-beta-fluoromethylene-m-tyramine [MeSH Supplementary Concept]
- 2-(3'-bromo-4'-hydroxyphenol)ethanamine [MeSH Supplementary Concept]
- 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine [MeSH Supplementary Concept]
- 2-(4-chloro-3-hydroxyphenyl)ethylamine [MeSH Supplementary Concept]
- 3,5-dibromo-4-methoxy-beta-phenethylamine [MeSH Supplementary Concept]
- 3-aminotyramine [MeSH Supplementary Concept]
- 3-bromo-N-methyltyramine [MeSH Supplementary Concept]
- 3-diazotyramine [MeSH Supplementary Concept]
- 3-methoxy-4-hydroxyphenylethylamine [MeSH Supplementary Concept]
- 3-methoxyphenethylamine [MeSH Supplementary Concept]
- 3-nitrotyramine [MeSH Supplementary Concept]
- 3-tyramine [MeSH Supplementary Concept]
- 4, alpha-dimethyl-3-tyramine [MeSH Supplementary Concept]
- 4-O-(sulfamoyl)-N-tetradecanoyltyramine [MeSH Supplementary Concept]
- 4-amino-3-hydroxyphenylethylamine [MeSH Supplementary Concept]
- 4-deoxy-7,8-dihydrotubastrine [MeSH Supplementary Concept]
- 7'-ethoxy-trans-feruloyltyramine [MeSH Supplementary Concept]
- 7,8-dihydrotubastrine [MeSH Supplementary Concept]
- 7,8-dimethylisoalloxazino-10-acetic acid-tyramine (1-1) tetrahydrate complex [MeSH Supplementary Concept]
- 7-hydroxyceratinamine [MeSH Supplementary Concept]
- Cy3.29-tyramide [MeSH Supplementary Concept]
- FITC-tyramide [MeSH Supplementary Concept]
- N,N-dimethyl-4-methoxyphenylethylamine [MeSH Supplementary Concept]
- N-(2-(4-hydroxyphenyl)ethyl)heneicosanamide [MeSH Supplementary Concept]
- N-(2-(4-hydroxyphenyl)ethyl)hentriacontanamide [MeSH Supplementary Concept]
- N-(2-(4-hydroxyphenyl)ethyl)nonacosanamide [MeSH Supplementary Concept]
- N-(2-hydroxybenzoyl)tyramine [MeSH Supplementary Concept]
- N-(2-methylpropionyl)-3-nitrotyramine [MeSH Supplementary Concept]
- N-(3-hydroxy-4-methoxycinnamoyl)tyramine [MeSH Supplementary Concept]
- N-acetyltyramine [MeSH Supplementary Concept]
- N-caffeoyltyramine [MeSH Supplementary Concept]
- N-chloroacetyliodotyramine [MeSH Supplementary Concept]
- N-chloroacetyltyramine [MeSH Supplementary Concept]
- N-cinnamoyltyramine [MeSH Supplementary Concept]
- N-coumaroyltyramine [MeSH Supplementary Concept]
- N-guanyltyramine [MeSH Supplementary Concept]
- N-hydroxycinnamoyltyramine [MeSH Supplementary Concept]
- N-iodoacetyltyramine [MeSH Supplementary Concept]
- N-methyl-2-(4-acetoxyphenyl)-2-chloroethanamine [MeSH Supplementary Concept]
- N-nicotinoyl tyramine [MeSH Supplementary Concept]
- N-nitroso-N-(2-hexanonyl)-3'-nitrotyramine [MeSH Supplementary Concept]
- N-nitroso-N-(3-keto-1,2-butanediol)-3'-nitrotyramine [MeSH Supplementary Concept]
- N-nitroso-N-methyltyramine [MeSH Supplementary Concept]
- N-trans-feruloyl-3-methoxytyramine-4'-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- O-(2-acetamidoethyl)-N-acetyltyramine [MeSH Supplementary Concept]
- O-methyltyramine [MeSH Supplementary Concept]
- Riparin IV [MeSH Supplementary Concept]
- YUA001 [MeSH Supplementary Concept]
- aphrocallistin [MeSH Supplementary Concept]
- becatamide [MeSH Supplementary Concept]
- biotin tyramine [MeSH Supplementary Concept]
- biotinyltyramide [MeSH Supplementary Concept]
- dihydro-N-caffeoyltyramine [MeSH Supplementary Concept]
- dilactitol tyramine [MeSH Supplementary Concept]
- enferamide [MeSH Supplementary Concept]
- ethynyltyramine [MeSH Supplementary Concept]
- feruloyltyramine [MeSH Supplementary Concept]
- galloyl tyramine [MeSH Supplementary Concept]
- gamma-glutamyl tyramine [MeSH Supplementary Concept]
- hexanoyldiiodo-N-(4-azido-2-nitrophenyl)tyramine [MeSH Supplementary Concept]
- hordenine [MeSH Supplementary Concept]
- inulin-tyramine [MeSH Supplementary Concept]
- iodotyramine-3-(propionyldithio)propionic acid-poly(lysine) [MeSH Supplementary Concept]
- iodotyramine-cellobiitol [MeSH Supplementary Concept]
- methyl-4-tyramine [MeSH Supplementary Concept]
- moloka'iamine [MeSH Supplementary Concept]
- norbelladine [MeSH Supplementary Concept]
- oretamide [MeSH Supplementary Concept]
- riparin III [MeSH Supplementary Concept]
- teuvisside A [MeSH Supplementary Concept]
- teuvisside B [MeSH Supplementary Concept]
- teuvisside F [MeSH Supplementary Concept]
- trans-N-p-coumaroyl tyramine [MeSH Supplementary Concept]
- tyramine O-sulfate [MeSH Supplementary Concept]
- tyramine glucuronide [MeSH Supplementary Concept]
- tyramine-cellobiose adduct [MeSH Supplementary Concept]
- tyramine-deoxysorbitol [MeSH Supplementary Concept]
- veskamide [MeSH Supplementary Concept]
Semantic type(s)
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Tyramine [LOINC component]
- Tyramine (substance) [SNOMED CT concept]
- tyramine [Substance BNPC]
- tyramine [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients